论文部分内容阅读
目的:研究分析氯吡格雷与阿司匹林治疗冠心病的临床效果和不良反应。方法:选取本院2015年1月~2016年4月期间诊治的冠心病患者133例,采取双盲对照方式将患者随机性划分为两组,其中67例采用氯吡格雷药物治疗,设置为氯吡格雷组,余下66例则选择常规用药阿司匹林治疗,设置为阿司匹林组,对比疗效临床疗效,统计分析两组用药期间药物副作用发生情况。结果:氯吡格雷组患者治疗总有效率高达95.52%(64/67),阿司匹林组患者治疗总有效率为84.85%(56/66);两组对比,氯吡格雷组临床疗效显著高于阿司匹林组,差异明显有统计学意义(P<0.05)。结论:在治疗冠心病方面可首选氯吡格雷,其疗效确切,安全可靠,值得推广。
Objective: To study the clinical effects and adverse reactions of clopidogrel and aspirin in the treatment of coronary heart disease. Methods: A total of 133 CHD patients diagnosed and treated during our hospital from January 2015 to April 2016 were selected. Patients were randomized into two groups by double-blind comparison. Among them, 67 patients were treated with clopidogrel drug and set as chlorine The other 66 patients were treated with aspirin, and aspirin was given as the aspirin group. The clinical efficacy was compared with that of the aspirin group. The side effects of the drugs during the two groups were statistically analyzed. Results: The total effective rate of clopidogrel group was 95.52% (64/67), while the total effective rate of aspirin group was 84.85% (56/66). The clinical efficacy of clopidogrel group was significantly higher than that of aspirin group Group, the difference was statistically significant (P <0.05). Conclusion: Clopidogrel can be the first choice in the treatment of coronary heart disease, its curative effect is exact, safe and reliable, it is worth to be popularized.